In November 2013, more than 100 patients with cancer – including pancreatic, breast, liver and brain tumours – embarked on clinical trials involving BPM 31510, a drug discovered by an algorithm. The story of BPM 31510 begins with the extraction of biological data from healthy and cancerous tissue samples from over 1,000 patients. This data…